Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 9/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | KDM1A | O60341 | 1/20 | 0.45 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | PTGES | O14684 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21889082 | 0.96 | KDM1A (0.51) | METAP2MEN1RAB9AKMT2AKDM1A | |
| SCHEMBL21888858 | 0.92 | NPY5R (0.50) | METAP2MEN1RAB9AKMT2AKDM1A | |
| SCHEMBL21076076 | 0.82 | METAP2 (0.48) | METAP2MEN1KMT2AKDM1ANLRP3 | |
| SCHEMBL13620583 | 0.78 | KDM4E (0.54) | METAP2MEN1KMT2AKDM1ANPY5R | |
| SCHEMBL13620587 | 0.78 | KDM4E (0.54) | METAP2MEN1KMT2AKDM1ANPY5R | |
| SCHEMBL16865779 | 0.77 | KDM1A (0.50) | METAP2MEN1KMT2AKDM1ANPY5R | |
| SCHEMBL24667916 | 0.76 | TSPO (0.53) | METAP2MEN1KMT2AKDM1ANLRP3 | |
| SCHEMBL14114045 | 0.76 | NPY5R (0.57) | MEN1KMT2AKDM1ANPY5RPTGES | |
| SCHEMBL16639587 | 0.76 | PTGES (0.53) | MEN1RAB9AKMT2AKDM1ANPY5R | |
| SCHEMBL14805227 | 0.75 | NPY5R (0.59) | MEN1KMT2ANPY5RPTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11584739-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-02-21 | — | — | US | disclosed |
| US-20200115364-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115364-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, CLTB, CYBA | METAP2 1252/4885MEN1 3395/4885RAB9A 3388/4885 |
| US-11584739-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, CLTB, CYBA | METAP2 1252/4885MEN1 3395/4885RAB9A 3388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.